Table 2 Relation between performance status and BCLC (n = 262).

From: ALBI-sarcopenia score as a predictor of treatment outcomes in hepatocellular carcinoma

 

Performance status

χ2

p

PS0

(n = 157)

PS1

(n = 76)

PS2

(n = 29)

BCLC

 BCLC A

65 (41.4%)

9 (11.8%)

0 (0.0%)

61.092*

<0.001*

 BCLC B

80 (51.0%)

49 (64.5%)

13 (44.8%)

 BCLC C

12 (7.6%)

18 (23.7%)

16 (55.2%)

  1. χ2: Chi square test, p: p value for Relation between Performance Status and BCLC, *: Statistically significant at p ≤ 0.05.
Back to article page